Literature DB >> 17522988

Methylphenidate effect on hemispheric attentional imbalance in patients with traumatic brain injury: a psychophysical study.

Marina Pavlovskaya1, Shaul Hochstein, Ofer Keren, Eugene Mordvinov, Zeev Groswasser.   

Abstract

PRIMARY
OBJECTIVE: We found spatially asymmetric allocation of attention in patients with traumatic brain injury (TBI) without overt asymmetry on neurological examination. The possible effect of Methylphenidate in reducing this asymmetry is evaluated in the current research. RESEARCH
DESIGN: Psychophysical study using a visual spatial attention task. Identification rates were measured after precuing attention to different visual field loci. TBI patients were tested before, during and after administration of Methylphenidate. METHODS AND PROCEDURES: After precuing to a locus 5 degrees into the left or right hemifield, target patterns were presented briefly at the cued location (valid), or on the opposite side (invalid) - requiring an attentional shift. Patients were treated with a gradually increasing dosage of a psychostimulant over two weeks, followed by a similar two-week period of gradually diminishing dosage. Patients were tested before treatment, at its peak, and (twice) following its completion. MAIN OUTCOME AND
RESULTS: Patients demonstrated significantly worse performance with leftward than with rightward cross-hemifield shifts of attention. This difference was significantly reduced during and following treatment.
CONCLUSIONS: Asymmetric performance and improvement with treatment suggest that diffuse TBI damage leads to a lateralized attention-related deficit. These findings support the hypotheses that attention is a distributed and asymmetrically lateralized function. The findings are consistent with the conclusion that Methylphenidate may be an effective treatment for attentional deficits in TBI patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522988     DOI: 10.1080/02699050701311117

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  10 in total

Review 1.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

2.  Parcellating the neuroanatomical basis of impaired decision-making in traumatic brain injury.

Authors:  Virginia F J Newcombe; Joanne G Outtrim; Doris A Chatfield; Anne Manktelow; Peter J Hutchinson; Jonathan P Coles; Guy B Williams; Barbara J Sahakian; David K Menon
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

Review 3.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

4.  Auditory orienting and inhibition of return in mild traumatic brain injury: a FMRI study.

Authors:  Andrew R Mayer; Maggie V Mannell; Josef Ling; Robert Elgie; Charles Gasparovic; John P Phillips; David Doezema; Ronald A Yeo
Journal:  Hum Brain Mapp       Date:  2009-12       Impact factor: 5.038

5.  Understanding the neurotransmitter changes underlying cognitive dysfunction in traumatic brain injury and possible therapeutic targets: a review.

Authors:  Ping Zheng; Wusong Tong
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

Review 6.  Concussion is confusing us all.

Authors:  David J Sharp; Peter O Jenkins
Journal:  Pract Neurol       Date:  2015-06

Review 7.  Executive (dys)function after traumatic brain injury: special considerations for behavioral pharmacology.

Authors:  Jenny E Ozga; Jessica M Povroznik; Elizabeth B Engler-Chiurazzi; Cole Vonder Haar
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

8.  Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.

Authors:  Martin P Paulus; Rayus Kuplicki; Teresa A Victor; Hung-Wen Yeh; Sahib S Khalsa
Journal:  BMC Psychiatry       Date:  2021-11-19       Impact factor: 3.630

Review 9.  Catecholamines and cognition after traumatic brain injury.

Authors:  Peter O Jenkins; Mitul A Mehta; David J Sharp
Journal:  Brain       Date:  2016-06-02       Impact factor: 13.501

Review 10.  Novel Synthetic and Natural Therapies for Traumatic Brain Injury.

Authors:  Denise Battaglini; Dorota Siwicka-Gieroba; Patricia Rm Rocco; Fernanda Ferreira Cruz; Pedro Leme Silva; Wojciech Dabrowski; Iole Brunetti; Nicolò Patroniti; Paolo Pelosi; Chiara Robba
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.